现金管理

Search documents
安旭生物: 安旭生物第二届监事会第十六次会议决议公告
Zheng Quan Zhi Xing· 2025-08-06 10:17
Group 1 - The company held its 16th meeting of the second supervisory board, with all three supervisors present, ensuring compliance with relevant laws and regulations [1] - The supervisory board approved the proposal to cancel the supervisory board and amend the company's articles of association, transferring the supervisory responsibilities to the audit committee of the board of directors [1][2] - The proposal to use part of the temporarily idle self-owned funds for cash management was also approved, allowing the company to invest up to RMB 4 billion in safe and liquid financial products [2][3] Group 2 - The supervisory board emphasized that it will continue to fulfill its supervisory duties until the shareholders' meeting approves the cancellation of the supervisory board, ensuring the protection of the company's and shareholders' interests [2] - The cash management proposal is aimed at improving the efficiency and return of fund usage while ensuring the company's normal operations and fund safety [3]
安旭生物(688075.SH):拟使用不超40亿元的部分暂时闲置自有资金进行现金管理
Ge Long Hui A P P· 2025-08-06 09:45
Core Viewpoint - Anxu Bio (688075.SH) plans to utilize up to RMB 4 billion of its temporarily idle self-owned funds to purchase low-risk, high-liquidity investment products through qualified financial institutions, with a usage period effective from September 18, 2025, for 12 months [1] Group 1 - The company intends to invest in safe and liquid financial products, including but not limited to principal-protected investment products, structured deposits, large-denomination certificates of deposit, and time deposits [1] - The investment will be executed through banks and securities companies that have legal operating qualifications [1] - The funds can be rolled over within the specified limit and duration [1]
宏工科技股份有限公司 关于使用部分闲置自有资金进行现金管理的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-08-06 00:24
Core Viewpoint - The company has approved the use of idle raised funds and self-owned funds for cash management, ensuring that it does not affect the normal operation of fundraising investment plans and the safety of raised funds [1] Group 1: Cash Management Approval - The company and its subsidiaries are authorized to use up to 100 million yuan of idle raised funds and up to 300 million yuan of self-owned funds for cash management within 12 months from the board's approval date [1] - The investment period for individual cash management products will not exceed 12 months [1] Group 2: Cash Management Implementation - The subsidiary, Hunan Hongong Intelligent Technology Co., Ltd., has utilized part of its idle self-owned funds for cash management [1] - The company has a total of 100 million yuan in unused self-owned funds for cash management as of the announcement date, which is within the authorized limit set by the board [3] Group 3: Risk Control Measures - The company will track and analyze the net value changes of cash management products and take necessary measures if risks to fund safety are identified [2] - Independent directors and the supervisory board have the authority to supervise and inspect the use of funds for related products [2] - The company will fulfill its information disclosure obligations according to the regulations of the Shenzhen Stock Exchange [2] Group 4: Impact on Company Operations - The use of idle self-owned funds for cash management will not affect the company's normal production and operation, as the purchased products are highly liquid and safe [3]
深圳华大智造科技股份有限公司 关于开立募集资金现金管理专用结算账户的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-08-06 00:19
Core Viewpoint - The company has approved the use of idle self-owned funds and temporarily idle raised funds for cash management, ensuring that it does not affect the implementation of fundraising projects and the normal development of its main business [1][3]. Group 1: Cash Management Approval - The company plans to use up to RMB 20 billion of idle self-owned funds and up to RMB 17 billion of temporarily idle raised funds for cash management, focusing on high-security and high-liquidity deposit products or capital-protected products [1]. - The approved cash management will be valid for 12 months from the date of the board's approval, allowing for the funds to be used in a rolling manner within the specified limits [1]. Group 2: Special Settlement Account - The company has recently opened a special settlement account for cash management of raised funds, which will only be used for the settlement of temporarily idle raised funds [2]. - The account will be closed promptly when cash management products mature and there are no further purchase plans [2]. Group 3: Risk Control Measures - The company will strictly adhere to relevant regulations and internal policies when conducting cash management activities, with the finance department monitoring investment risks [3]. - The audit department and supervisory board have the authority to supervise and inspect the use of funds, and may hire professional institutions for auditing if necessary [3]. Group 4: Impact on the Company - The use of idle raised funds for cash management is expected to enhance fund utilization efficiency and generate investment returns, ultimately benefiting the company's performance and providing greater returns for shareholders [3].
华大智造股价小幅回落 公司开立募集资金现金管理账户
Jin Rong Jie· 2025-08-05 20:07
Group 1 - The stock price of BGI Genomics is reported at 67.76 yuan, down 1.15% from the previous trading day, with an intraday high of 69.35 yuan and a low of 67.19 yuan, and a trading volume of 2.11 billion yuan [1] - BGI Genomics' main business includes the research, development, production, and sales of instruments and consumables related to life sciences and healthcare, covering products such as gene sequencers and laboratory automation equipment [1] - The company has recently opened a special settlement account for cash management of raised funds, planning to use up to 2 billion yuan of idle self-owned funds and 1.7 billion yuan of idle raised funds for cash management, focusing on purchasing safe and liquid deposit-type or capital-protected products [1]
北京挖金客信息科技股份有限公司关于使用暂时闲置募集资金和自有资金进行现金管理的进展公告
Shang Hai Zheng Quan Bao· 2025-08-05 19:00
Core Viewpoint - The company has approved the use of temporarily idle raised funds and self-owned funds for cash management, aiming to enhance fund utilization efficiency and generate investment returns [1][7]. Group 1: Cash Management Approval - The company plans to use up to 100 million yuan of temporarily idle raised funds and up to 150 million yuan of self-owned funds for cash management, with investments in high-security and high-liquidity products, with a maximum investment period of 12 months [1][2]. - The board and supervisory committee have approved this cash management initiative during their meetings held on November 27, 2024 [1]. Group 2: Cash Management Progress - The company has reported on the redemption of cash management products, confirming that the actual returns align with expected returns, and the principal and earnings have been deposited into the respective accounts [2]. - The cash management activities do not involve related parties and do not constitute a major asset restructuring as per regulations [3]. Group 3: Risk Control Measures - The company has established strict evaluation processes for investment products to mitigate risks associated with market fluctuations [4]. - Various risk control measures include selecting appropriate cash management products, timely analysis of investment performance, and regular audits by the company's audit department [5][6]. Group 4: Impact on the Company - The cash management initiative is designed to ensure that it does not affect the company's normal operations or the implementation of fundraising projects, thereby benefiting the company and its shareholders [7]. - The company will comply with regulatory requirements for timely disclosure of cash management progress [7]. Group 5: Current Cash Management Status - As of July 31, 2025, the company has no outstanding cash management products using raised funds, while the cumulative balance of self-owned funds in cash management is 31.4 million yuan, within the authorized limits [8][9].
圣湘生物: 圣湘生物科技股份有限公司第三届董事会2025年第一次临时会议决议公告
Zheng Quan Zhi Xing· 2025-08-05 16:33
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码:688289 证券简称:圣湘生物 公告编号:2025-055 圣湘生物科技股份有限公司 第三届董事会 2025 年第一次临时会议决议公告 一、董事会会议召开情况 圣湘生物科技股份有限公司(以下简称"公司")第三届董事会 2025 年第一次 临时会议于 2025 年 8 月 5 日以现场结合通讯方式召开,会议通知已于 2025 年 8 月 1 日以邮件方式送达全体董事。第三届董事会全体董事推举董事戴立忠先生主持会议, 应出席董事 11 人,实际出席董事 11 人。会议的通知、召开及审议程序符合《中华人 民共和国公司法》(以下简称"《公司法》")和《公司章程》的有关规定。 二、董事会会议审议情况 经与会董事审议,一致通过如下议案: 委员会委员的议案》 内容:公司第三届董事会各专门委员会的具体组成如下: (1)战略委员会:戴立忠(主任委员)、马骥、肖朝君; (2)审计委员会:王善平(主任委员)、肖朝君、任小梅; (3)提名委员会:肖朝君(主任委员)、马骥、戴立忠; (4) ...
邦彦技术: 第四届董事会第四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-05 16:33
证券代码:688132 证券简称:邦彦技术 公告编号: 2025-051 邦彦技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 邦彦技术股份有限公司(以下简称"公司")第四届董事会第四次会议于2025 年8月5日采用通讯表决的方式召开。全体董事一致同意本次会议豁免《公司法》以 及《公司章程》所要求之会议通知时限要求,且不会以任何途径及方式向相关部门 及机关申请撤销公司本次临时董事会的决议。公司以邮件等通讯方式向全体董事发 出召开本次会议的通知,与会的各位董事已知悉与所议事项相关的必要信息。会议 应出席董事7人,实际出席董事7人,会议由董事长祝国胜主持,本次会议的召开符 合有关法律、法规和《公司章程》的规定,会议决议合法、有效。 二、董事会会议审议情况 经全体董事表决,形成决议如下: (一)审议通过《关于 <公司2025年员工持股计划 草案="草案"> 及其摘要的议案》 表决结果:5票同意,0票反对,0票弃权。关联董事胡霞、李晶晶回避表决。本 议案尚需提交公司股东会审议。 本议案已经公司第 ...
圣湘生物: 圣湘生物科技股份有限公司关于使用部分暂时闲置募集资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-05 16:33
证券代码:688289 证券简称:圣湘生物 公告编号:2025-052 圣湘生物科技股份有限公司 关于使用部分暂时闲置募集资金进行现金管理的 公告 公司对募集资金采取了专户存储制度,设立了相关募集资金专项账户。募集资金 到账后,已全部存放于该募集资金专项账户内,并与保荐人、存放募集资金的银行签 署了募集资金三方监管协议。具体情况详见 2020 年 8 月 27 日披露于上海证券交易所 网站(www.sse.com.cn)的《首次公开发行股票科创板上市公告书》。 二、募集资金投资项目情况 根据公司《首次公开发行股票并在科创板上市招股说明书》,公司本次发行新股 的实际募集资金扣除发行费用后的净额将全部用于与公司主营业务相关的项目,具体 如下: 净额为人民币 186,926.98 万元,其中超募资金 131,268.98 万元。中审众环会计师事务 所(特殊普通合伙)对公司本次公开发行新股的资金到位情况进行了审验,并出具了 《验资报告》(众环验字(2020)110009 号)。 《关于同意圣湘生物科 技股份有限公司首次公开发行股票注册的批复》 (证监许可[2020]1580 号),本公司于 本公司董事会及全体董事保证 ...
邦彦技术: 关于使用闲置自有资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-05 16:33
邦彦技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 邦彦技术股份有限公司(以下简称"邦彦技术"或"公司")于2025年8月5日 召开第四届董事会第四次会议审议通过了《关于使用闲置自有资金进行现金管理 的议案》,同意公司在 保 证 公 司 正 常 经 营 运 作 资 金 需 求 和 资 金 安 全 的 前 提 下 ,使用最高不超过人民币5亿元(含本数)的闲置自有资金进行现金管理,可 用于购买安全性高、流动性好的投资产品(包括但不限于协定性存款、结构 性存款、定期存款、大额存单、通知存款、收益凭证等),使用期限自公司 限范围内,资金可以循环滚动使用。 一、本次现金管理的概述 证券代码:688132 证券简称:邦彦技术 公告编号:2025-053 (五)实施方式 授权公司总经理在上述额度及决议有效期内行使投资决策权、签署相关文 件等事宜,包括但不限于:选择合格的专业金融机构、明确现金管理金额、期 间、选择产品/业务品种、签署合同及协议等。 (六)信息披露 (一)现金管理的目的 为提高公司资金使用 ...